1 |
Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 1990;33: 1114-21.
|
2 |
Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006;65:936-41.
|
3 |
Kim S, Yoon J, Jeong S. Comparison of the clinical manifestations and prognosis of Henoch-Schonlein purpura in children with and without abdominal pain. Korean J Pediatr Gastroenterol Nutr 2011;14:359-67.
DOI
|
4 |
Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005;35:143-53.
DOI
|
5 |
Calvino MC, Llorca J, Garcia-Porrua C, Fernandez-Iglesias JL, Rodriguez-Ledo P, Gonzalez-Gay MA. Henoch-Schonlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore) 2001;80:279-90.
DOI
|
6 |
Hung SP, Yang YH, Lin YT, Wang LC, Lee JH, Chiang BL. Clinical manifestations and outcomes of Henoch-Schonlein purpura: comparison between adults and children. Pediatr Neonatol 2009;50:162-8.
DOI
|
7 |
Martinez-Frontanilla LA, Haase GM, Ernster JA, Bailey WC. Surgical complications in Henoch-Schonlein Purpura. J Pediatr Surg 1984;19:434-6.
DOI
|
8 |
Faille-Kuyber EH, Kater L, Kooiker CJ, Dorhout Mees EJ. IgA-deposits in cutaneous blood-vessel walls and mesangium in Henoch-Schonlein syndrome. Lancet 1973;1:892-3.
|
9 |
Besbas N, Saatci U, Ruacan S, Ozen S, Sungur A, Bakkaloglu A, et al. The role of cytokines in Henoch Schonlein purpura. Scand J Rheumatol 1997;26:456-60.
DOI
|
10 |
Claudy A. Coagulation and fibrinolysis in cutaneous vasculitis. Clin Dermatol 1999;17:615-8.
|
11 |
Ates E, Bakkaloglu A, Saatci U, Soylemezoglu O. von Willebrand factor antigen compared with other factors in vasculitic syndromes. Arch Dis Child 1994;70:40-3.
DOI
|
12 |
Hergesell O, Andrassy K, Nawroth P. Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis. Thromb Haemost 1996;75:892-8.
|
13 |
Rose PE, Struthers GS, Robertson M, Kavi J, Chant I, Taylor CM. Factor VIII von Willebrand protein in haemolytic uraemic syndrome and systemic vasculitides. Lancet 1990;335:500-2.
DOI
|
14 |
De Mattia D, Penza R, Giordano P, Del Vecchio GC, Aceto G, Altomare M, et al. von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura. Pediatr Nephrol 1995;9:603-5.
DOI
|
15 |
Yang YH, Yu HH, Chiang BL. The diagnosis and classification of Henoch-Schonlein purpura: an updated review. Autoimmun Rev 2014;13:355-8.
DOI
|
16 |
Yilmaz D, Kavakli K, Ozkayin N. The elevated markers of hypercoagulability in children with Henoch-Schonlein purpura. Pediatr Hematol Oncol 2005;22:41-8.
DOI
|
17 |
Saulsbury FT. Henoch-Schonlein purpura. Curr Opin Rheumatol 2010;22:598-602.
DOI
|
18 |
Yang YH, Chuang YH, Wang LC, Huang HY, Gershwin ME, Chiang BL. The immunobiology of Henoch-Schonlein purpura. Autoimmun Rev 2008;7:179-84.
DOI
|
19 |
Levi M, van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005;15:254-9.
DOI
|
20 |
Szaba FM, Smiley ST. Roles for thrombin and fibrin( ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood 2002;99:1053-9.
DOI
|
21 |
Del Vecchio GC, Penza R, Altomare M, Piacente L, Aceto G, Lassandro G, et al. Cytokine pattern and endothelium damage markers in Henoch-Schonlein purpura. Immunopharmacol Immunotoxicol 2008;30:623-9.
DOI
|
22 |
Dalens B, Travade P, Labbe A, Bezou MJ. Diagnostic and prognostic value of fibrin stabilising factor in Schonlein-Henoch syndrome. Arch Dis Child 1983;58: 12-4.
DOI
|
23 |
Kamitsuji H, Tani K, Yasui M, Taniguchi A, Taira K, Tsukada S, et al. Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch-Schonlein purpura. Efficacy of factor XIII substitution. Eur J Pediatr 1987;146:519-23.
DOI
|
24 |
Kang Y, Park JS, Ha YJ, Kang MI, Park HJ, Lee SW, et al. Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schonlein purpura. J Korean Med Sci 2014;29:198-203.
DOI
|
25 |
Brendel-Muller K, Hahn A, Schneppenheim R, Santer R. Laboratory signs of activated coagulation are common in Henoch-Schonlein purpura. Pediatr Nephrol 2001; 16:1084-8.
DOI
|